Alloway Advised FDA at Public Hearing
On June 21, Rita Alloway, PharmD, research professor in the division of nephrology and hypertension, participated in a Food and Drug Administration public hearing, "Generic Drug User Fee Amendments of 2012 Regulatory Science initiatives: Request for Public Input for FY 2014 Generic Drug Research The Food and Drug Administration.
Alloway represented the American Society of Transplantation to advise the FDA related to future research efforts in generic drug use in transplantation. In addition to reviewing the status of the currently FDA funded U01, she provided specific study recommendations for future studies.
Tags
Related Stories
On-site training in Speech & Hearing Clinic sets UC’s programs apart
August 27, 2026
At the University of Cincinnati’s Speech & Hearing Clinic, Doctor of Audiology and Speech-Language Pathology graduate students gain real-world experience while providing free speech and hearing services to the community.
Funding expands UC research into weight gain side effects of bipolar medication
August 26, 2026
University of Cincinnati researchers have been approved for funding by the Patient-Centered Outcomes Research Institute (PCORI) to expand the implementation of healthy lifestyle interventions and metformin prescription to help manage weight gain in overweight or obese youth taking second-generation antipsychotic medications.
One in four NFL players had CTE at death
August 25, 2026
Forbes cites research on concussions and football helmets by the University of Cincinnati in a report that found one in four NFL players had brain damage at death.